Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Financial Performance and Strategy news
19 August 2026
Avantium advances FDCA Flagship Plant start-up and readies financing package
Oxidation unit commissioned; full start-up and first FDCA production targeted end‑2026; 22 offtakes and >150 kt reservations secured; pursuing €55m equity plus a €20m NOM loan.
19 August 2026
PETRONAS Chemicals Group posts resilient 2Q 2026 earnings amid major turnarounds
Improved earnings despite reduced plant utilisation from major planned turnarounds; revenue RM7.9bn, EBITDA RM1.3bn and interim dividend RM480m.
18 August 2026
dsm-firmenich proposes Richard Ridinger as new chair after Thomas Leysen retirement
Board chair Thomas Leysen will retire; shareholders will vote on Richard Ridinger at an Extraordinary General Meeting on 19 Oct 2026.
18 August 2026
KazMunayGas H1 2026 financial results
Revenue +23.7% to 5,568 bln tenge; EBITDA +45% to 1,655 bln; net profit +69.1% to 904 bln; net debt rose to 983 bln tenge as cash/deposits declined.
14 August 2026
WuXi Biologics to divest 51.1% stake in Bestchrom
Selling 51.1% stake in Bestchrom; deal expected by December 2026. Bestchrom supplies chromatography resins, columns and downstream process development services.
14 August 2026
Rompetrol Rafinare posts solid H1 2026 results
Consolidated turnover +25% to USD 3.5bn; EBITDA +65% to USD 128.1m and net profit USD 40.4m. Petromidia shifted output toward domestic market; H2 outlook cautious.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
14 August 2026
SOCAR posts 86.3 billion manat revenue and 10.9 billion manat EBITDA in 2025
Revenues 86.3bn manats; total profit 12.6bn and net profit ~3.0bn. EBITDA rose 26%. Major field acquisitions and a 136% jump in operating cash flow.
14 August 2026
LanzaTech Q2 2026 financial results
Cost cuts and an equity valuation gain lift results; advancing ISCC EU recycled-fuel certification in China and selecting Ghent for a commercial-scale SAF facility.
14 August 2026
SOCAR 2025 results: AZN 86.3bn revenue, AZN 10.9bn EBITDA
Revenue driven by crude, petroleum and gas sales; EBITDA rose 26% and net profit ≈AZN 3.0bn amid major field acquisitions and stronger operating cash flow.
13 August 2026
CATL earns S&P Global Tier 1 for cells and systems and leads global storage market
Dual Tier 1 recognition and No.1 market-share ranking in both battery cells and energy storage systems by S&P Global Energy.
13 August 2026
thyssenkrupp Q3 2025/26: sales up and adjusted EBIT improves as strategic realignment advances
Order intake fell to €7.7bn; adjusted EBIT forecast raised to €600–900m; shareholders approved tk accelis spin-off; TKMS backlog >€20bn with major July contract wins.
13 August 2026
LKAB Q2 2026: Earnings hit by USD hedging and higher costs
Stable production and deliveries but lower sales and operating profit due to USD hedging losses and higher energy, maintenance and urban transformation costs; two key permits granted.
12 August 2026
Bilfinger Q2 2026 financial results
Revenue rose 7% to €1,450m while orders fell 16% to €1,498m; EBITA margin 5.3%. Outlook confirmed: revenue €5.4–€5.9bn, FCF €250–€300m (includes Teknokon).
12 August 2026
Brenntag Q2 2026 results — sales €4.3bn; guidance raised
Sales up 11% to €4.3bn; operating EBITDA +41% to €463m; gross margin rose to 26.9%. Guidance increased to €1,350–1,450m for 2026.
12 August 2026
SOCAR 2025 Sustainability Report
First Double Materiality Assessment, new ESG Data Platform and Decarbonization Roadmap; ~1 million tCO₂e avoided, USD 200m Green Bonds and local procurement at 88%.
10 August 2026
PTT Global Chemical (GC) starts new growth chapter — petrochemicals, specialty & Green‑Bio, Map Ta Phut
Q2 adjusted EBITDA THB 26.932bn; ethane imports from the US due 2029; portfolio shift to 70:30 specialty by 2030; USD 300m EBITDA uplift target by 2030.
10 August 2026
PTT Global Chemical strengthens petrochemicals, accelerates Specialty and Green & Bio; positions Map Ta Phut as APAC growth base
Reinforces integrated petrochemical core, starts ethane imports in 2029, shifts toward higher‑value Specialty and Green & Bio, and expands Map Ta Phut as a regional hub.
7 August 2026
MOL Group Q2 2026 results
Q2 profit USD 786m; strong oil and gas prices plus higher refining and petrochemical margins offset fuel price caps and operational outages.
7 August 2026
LANXESS posts higher Q2 2026 sales and EBITDA pre exceptionals
Sales up 6.5% to EUR 1.561bn; EBITDA pre exceptionals EUR 152m; QoQ earnings jump 61.7%; full-year EBITDA guidance EUR 450–550m confirmed.
7 August 2026
FY2026 1Q consolidated results
Q1 sales and profits rose on higher methanol and polycarbonate prices, inventory gains and yen weakness; full-year guidance lifted and dividend increased, but methanol-price risk remains.
6 August 2026
Trinseo Q2 2026 financial results
Net loss $120M; adjusted EBITDA $81M; free cash flow negative $125M; advancing DIP-backed debt restructuring and restarted Americas Styrenics sale.
6 August 2026
PureCycle Technologies Q2 2026 results and commercial ramp
Revenue $4.5M; first P&G resin deliveries; PureFive approved as post‑consumer recycled content in New Jersey; Ironton compounding online; liquidity $236.9M.
6 August 2026
Petrobras posts R$52.4bn Q2 2026 profit
Quarterly results bolstered by record own oil output, above-100% refinery utilization and higher derivative production, supporting cash generation and lower imports.
6 August 2026
ORLEN Group posts record Q2 2026 profits and PLN 14.7bn H1 capex
Q2 results: revenue PLN 76.5bn, LIFO EBITDA PLN 13.9bn, net profit PLN 7.7bn; record foreign retail profits and H1 capital expenditure PLN 14.7bn.
6 August 2026
Aurubis raises full‑year outlook after stronger Q3 and major project progress
Group EBT and ROCE improved; Q3 outperformed prior quarters; large recycling plant started and ~90% of €1.7bn investment programme completed.
5 August 2026
SEQENS agrees in principle to comprehensive financial restructuring
Agreement in principle with creditors to deleverage the balance sheet, convert senior lenders into shareholders and preserve operations; completion expected by end of 2026.
5 August 2026
Eli Lilly Q2 2026 results: revenue +48%, raises guidance; retatrutide package complete
Revenue rose 48% to $23.0bn driven by Mounjaro and Zepbound; updated 2026 revenue guidance to $85–87bn; retatrutide Phase 3 package complete supporting a Q1 2027 BLA.
4 August 2026
SABIC completes sale of Engineering Thermoplastics business in Americas and Europe to Mutares
Sale of ETP assets for $450 million improves EBITDA margin ~130–140 bps and removes a loss-making unit from the portfolio.
4 August 2026
Aramco Q2 and H1 2026 results
Strong H1 profits and cash flow; Q2 free cash flow hit by $13.6bn working-capital build. Dividend declared and key upstream/gas projects on track for 2026–27 completion.
3 August 2026
bp sells Gelsenkirchen refinery to Klesch Group
Sale reduces underlying opex by about $1 billion, is free-cash-flow accretive based on historical performance, and transfers assets, liabilities and employees.
Next →
